Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
HHS-OIG
OIG Releases FY 2017 Work Plan
The United States Health and Human Services (HHS) Office of Inspector General (OIG) recently released its 2017 Work Plan, which…
House Ways and Means Subcommittee on Oversight Holds Hearing on Health Care…
On Wednesday, September 28, 2016, the House Ways and Means Oversight Subcommittee held a hearing on Health Care Fraud…
CMS Reports $42 Billion Saved in Medicare and Medicaid
On July 20, 2016, CMS released a report that showed investments that are made in program integrity activities – such as…
E&C Subcommittee Hearing, HHS OIG and GAO Reports on Medicare and…
On May 24, 2016, the House Energy and Commerce Subcommittee on Oversight and Investigations held a hearing entitled, "Medicare and…
Do Gold-Standard CIAs Get Blue Ribbon Approval?
Corporate Integrity Agreements are thought to set the standard for compliance programs, but when viewed against the norms…
Public Citizen Study Shows Significant Reduction in Pharmaceutical…
Public Citizen updated that report, and issued a new report, which included settlements for all years, starting in 1991,…
Respironics Settlement and Corporate Integrity Agreement
One more False Claims Act case has been settled; this time Respironics, Inc., who allegedly violated the False Claims…
Healthcare Company Boards Must Understand How to Manage Risk
In the Corporate Integrity Agreement (CIA) entered into by Olympus Corporation of the Americas, the Office of Inspector…
Olympus Settlement and Corporate Integrity Agreement – FCPA and Anti…
The United States Department of Justice has announced a settlement with medical device maker Olympus, to the tune of…